448 related articles for article (PubMed ID: 31188324)
21. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
[No Abstract] [Full Text] [Related]
22. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
[TBL] [Abstract][Full Text] [Related]
23. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
24. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
Saleh M; Virarkar M; Javadi S; Elsherif SB; de Castro Faria S; Bhosale P
AJR Am J Roentgenol; 2020 May; 214(5):1182-1195. PubMed ID: 32182097
[No Abstract] [Full Text] [Related]
25. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
[TBL] [Abstract][Full Text] [Related]
27. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.
Liu X; Wang W; Hu K; Zhang F; Hou X; Yan J; Meng Q; Zhou Z; Miao Z; Guan H; Ma J; Shen J; Zhen H; Wang W
Sci Rep; 2020 Jan; 10(1):362. PubMed ID: 31941966
[TBL] [Abstract][Full Text] [Related]
28. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
[TBL] [Abstract][Full Text] [Related]
29. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
31. Validation of the 2021 FIGO staging schema for advanced vulvar cancer.
Matsuo K; Klar M; Nishio S; Mikami M; Roman LD; Wright JD
Int J Gynecol Cancer; 2022 Apr; 32(4):474-479. PubMed ID: 34996835
[TBL] [Abstract][Full Text] [Related]
32. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
33. Validation of the FIGO 2009 staging system for carcinoma of the vulva.
Tan J; Chetty N; Kondalsamy-Chennakesavan S; Crandon A; Garrett A; Land R; Nascimento M; Nicklin J; Perrin L; Obermair A
Int J Gynecol Cancer; 2012 Mar; 22(3):498-502. PubMed ID: 22367324
[TBL] [Abstract][Full Text] [Related]
34. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
[TBL] [Abstract][Full Text] [Related]
35. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
Cooke EW; Pappas L; Gaffney DK
Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
37. Early cervical adenocarcinoma: selection criteria for radical surgery.
Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
[TBL] [Abstract][Full Text] [Related]
38. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
39. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
